Newsroom

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Bloomberg Scarce Resources UCTS ETF 09.01.2026 SCAR LN IE000BW2B3J3 25,002.00 USD 705,303.72 28.210  ...

LONDON--(BUSINESS WIRE)--  09-January-2026 Issue: Newday Funding Master Issuer Plc 2025-2 Class A REG S XS3096170884 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-December-2025 Date To: 15-January-2026 Record Date: 14-January-2026 Value Date: 15-January-2026 Benchmark Rate: 3.84354% Margin: 0.8% Total Rate: 4.64354% Number of Days: 31 Day Count: Actual / 365 (Fixed) Interest Frequency: Monthly Total...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share FIRST TRUST INDXX FUTURE ECONOMY METALS UCITS ETF 09.01.2026 METL LN IE000UDFKE13 75,002.00 USD 2,567,519.97 34.233  ...

LONDON--(BUSINESS WIRE)--  09-January-2026 Issue: Newday Funding Master Issuer Plc 2025-1 Class F 144A XS3031615621 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-December-2025 Date To: 15-January-2026 Record Date: 14-January-2026 Value Date: 15-January-2026 Benchmark Rate: 3.84353568% Margin: 4.3% Total Rate: 8.14353568% Number of Days: 31 Day Count: Actual / 365L Interest Frequency: Monthly Total A...

MIAMI--(BUSINESS WIRE)--Cast AI, the leading Application Performance Automation platform, today introduced OMNI Compute, a unified compute control plane that automatically discovers available resources across cloud providers and regions and transparently extends existing Kubernetes clusters to consume them. The company also announced a strategic investment from Pacific Alliance Ventures (PAV), the U.S.-based corporate venture arm of Shinsegae Group, an over $50 billion Korean conglomerate with...

LONDON--(BUSINESS WIRE)--  09-January-2026 Issue: Newday Funding Master Issuer Plc Series 2023-1 Class A1 RegS XS2715923459 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-December-2025 Date To: 15-January-2026 Record Date: 14-January-2026 Value Date: 15-January-2026 Benchmark Rate: 3.84354% Margin: 1.5% Total Rate: 5.34354% Number of Days: 31 Day Count: Actual / 365L Interest Frequency: Monthly Total...

LONDON--(BUSINESS WIRE)--  09-January-2026 Issue: Newday Funding Master Issuer Plc Series 2024-3 Class D 144A XS2909752987 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-December-2025 Date To: 15-January-2026 Record Date: 14-January-2026 Value Date: 15-January-2026 Benchmark Rate: 3.84354% Margin: 2.3% Total Rate: 6.14354% Number of Days: 31 Day Count: Actual / 365L Interest Frequency: Monthly Total...

LONDON--(BUSINESS WIRE)--  09-January-2026 Issue: Newday Funding Master Issuer Plc 2025-1 Class F REGS XS3031616272 Pursuant to our appointment as Agent for the above stated issue, please be advised of the following interest rate determination: Date From: 15-December-2025 Date To: 15-January-2026 Record Date: 14-January-2026 Value Date: 15-January-2026 Benchmark Rate: 3.84354% Margin: 4.3% Total Rate: 8.14354% Number of Days: 31 Day Count: Actual / 365L Interest Frequency: Monthly Total Amount...

WESTBOROUGH, Mass.--(BUSINESS WIRE)--Kopin Corporation (NASDAQ: KOPN) a leading provider of application-specific optical systems and high-performance microdisplays for defense, training, enterprise, industrial, consumer and medical products, today announced that management will participate in the 28th Annual Needham Growth Conference, taking place virtually on January 16, 2026. Michael Murray, President and Chief Executive Officer of Kopin, is scheduled to present & host one-on-one meetings...

WALTHAM, Mass.--(BUSINESS WIRE)--Vicarious Surgical (NYSE: RBOT) (the “Company”), a next-generation robotics technology company seeking to improve lives by transforming robotic surgery, today announced the successful completion of an in-vivo porcine lab conducted in December 2025, marking a meaningful step forward in the development of the company’s robotic system and reinforcing progress toward system design freeze targeted for the end of 2026. During the lab, surgeons independently completed...